These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19541252)

  • 1. Hyperprolactinemia-related adverse events associated with antipsychotic treatment in children and adolescents.
    Jerrell JM; Bacon J; Burgis JT; Menon S
    J Adolesc Health; 2009 Jul; 45(1):70-6. PubMed ID: 19541252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
    McIntyre RS; Jerrell JM
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events in children and adolescents treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2008 Jun; 23(4):283-90. PubMed ID: 18302312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological adverse events associated with antipsychotic treatment in children and adolescents.
    Jerrell JM; Hwang TL; Livingston TS
    J Child Neurol; 2008 Dec; 23(12):1392-9. PubMed ID: 18772491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
    Mehta S; Johnson ML; Chen H; Aparasu RR
    J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS; Tripathi A
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events associated with psychotropic treatment in African American children and adolescents.
    Jerrell JM
    J Natl Med Assoc; 2010 May; 102(5):375-83. PubMed ID: 20533772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
    Fontanella CA; Bridge JA; Campo JV
    Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder.
    Jerrell JM; McIntyre RS; Tripathi A
    Hum Psychopharmacol; 2011 Oct; 26(7):451-9. PubMed ID: 21898598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
    Compton MT; Miller AH
    Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic screening in children receiving antipsychotic drug treatment.
    Morrato EH; Nicol GE; Maahs D; Druss BG; Hartung DM; Valuck RJ; Campagna E; Newcomer JW
    Arch Pediatr Adolesc Med; 2010 Apr; 164(4):344-51. PubMed ID: 20368487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics and parkinsonism.
    Rochon PA; Stukel TA; Sykora K; Gill S; Garfinkel S; Anderson GM; Normand SL; Mamdani M; Lee PE; Li P; Bronskill SE; Marras C; Gurwitz JH
    Arch Intern Med; 2005 Sep; 165(16):1882-8. PubMed ID: 16157833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
    Aparasu RR; Jano E; Johnson ML; Chen H
    Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2007 Aug; 22(6):361-4. PubMed ID: 17562519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.
    Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 4():26-36. PubMed ID: 18533766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-care costs of pediatric clients developing adverse events during treatment with antipsychotics.
    Jerrell JM; McIntyre RS
    Value Health; 2009; 12(5):716-22. PubMed ID: 19508657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of psychotropic-induced hyperprolactinemia.
    Marken PA; Haykal RF; Fisher JN
    Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual side effects associated with conventional and atypical antipsychotics.
    Compton MT; Miller AH
    Psychopharmacol Bull; 2001; 35(3):89-108. PubMed ID: 12397881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.